Il y a eu 50 transactions d'initiés récentes enregistrées pour Cabaletta Bio, Inc. (CABA), dont 37 achats et 12 ventes. Le total des achats d'initiés s'élève à $32.42M et le total des ventes d'initiés à $15.88M.
Les initiés notables ayant une activité récente comprennent Nichtberger Steven, Marda Anup, Chang David J.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CABA
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-02 |
Nichtberger Steven |
President & CEO |
Attribution de RSU |
674,000 |
$3.30 |
$2.22M |
674,000 |
| 2026-03-02 |
Marda Anup |
Chief Financial Officer |
Attribution de RSU |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Chang David J. |
Chief Medical Officer |
Attribution de RSU |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Binder Gwendolyn |
President, Science & Tech. |
Attribution de RSU |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Gerard Michael |
General Counsel |
Attribution de RSU |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-03-02 |
Das Arun |
Chief Business Officer |
Attribution de RSU |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-01-21 |
Simon Mark |
Director |
Achat Informatif |
11,061 |
$2.28 |
$25.26K |
147,205 |
| 2026-01-21 |
Nichtberger Steven |
President & CEO |
Achat Informatif |
45,000 |
$2.24 |
$100.78K |
1,031,483 |
| 2026-01-21 |
Tomasello Shawn |
Director |
Achat Informatif |
22,725 |
$2.21 |
$50.32K |
22,725 |
| 2026-01-21 |
Bollard Catherine |
Director |
Achat Informatif |
4,405 |
$2.27 |
$9.98K |
5,405 |
| 2026-01-21 |
Chang David J. |
Chief Medical Officer |
Achat Informatif |
8,800 |
$2.26 |
$19.89K |
8,800 |
| 2026-01-21 |
Binder Gwendolyn |
President, Science & Tech. |
Achat Informatif |
11,312 |
$2.19 |
$24.76K |
31,312 |
| 2026-01-21 |
Gerard Michael |
General Counsel |
Achat Informatif |
6,600 |
$2.27 |
$14.98K |
6,600 |
| 2026-01-21 |
Gavel Steve |
Chief Commercial Officer |
Achat Informatif |
22,170 |
$2.27 |
$50.22K |
22,170 |
| 2025-10-13 |
Gavel Steve |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-10-13 |
Gavel Steve |
Chief Commercial Officer |
Attribution de RSU |
275,000 |
$2.49 |
$684.75K |
275,000 |
| 2025-06-09 |
Henriques Richard C Jr |
Director |
Attribution de RSU |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Simon Mark |
Director |
Attribution de RSU |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Tomasello Shawn |
Director |
Attribution de RSU |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Bollard Catherine |
Director |
Attribution de RSU |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Brun Scott C. |
Director |
Attribution de RSU |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-05-19 |
Henriques Richard C Jr |
Director |
Restitution d'Actions |
22,000 |
$11.18 |
$245.96K |
- |
| 2025-05-19 |
Simon Mark |
Director |
Restitution d'Actions |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Nichtberger Steven |
President & CEO |
Restitution d'Actions |
411,600 |
$11.09 |
$4.56M |
- |
| 2025-05-19 |
Tomasello Shawn |
Director |
Restitution d'Actions |
44,000 |
$13.48 |
$593.12K |
- |
| 2025-05-19 |
Marda Anup |
Chief Financial Officer |
Restitution d'Actions |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Bollard Catherine |
Director |
Restitution d'Actions |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Chang David J. |
Chief Medical Officer |
Restitution d'Actions |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-05-19 |
Binder Gwendolyn |
President, Science & Tech. |
Restitution d'Actions |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Brun Scott C. |
Director |
Restitution d'Actions |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Gerard Michael |
General Counsel |
Restitution d'Actions |
75,000 |
$3.21 |
$240.75K |
- |
| 2025-05-19 |
Das Arun |
Chief Business Officer |
Restitution d'Actions |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-03-03 |
Nichtberger Steven |
President & CEO |
Attribution de RSU |
450,000 |
$1.67 |
$751.5K |
450,000 |
| 2025-03-03 |
Marda Anup |
Chief Financial Officer |
Attribution de RSU |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Chang David J. |
Chief Medical Officer |
Attribution de RSU |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Binder Gwendolyn |
President, Science & Tech. |
Attribution de RSU |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Gerard Michael |
General Counsel |
Attribution de RSU |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2025-03-03 |
Das Arun |
Chief Business Officer |
Attribution de RSU |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2024-06-03 |
Henriques Richard C Jr |
Director |
Attribution de RSU |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Simon Mark |
Director |
Attribution de RSU |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Tomasello Shawn |
Director |
Attribution de RSU |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Bollard Catherine |
Director |
Attribution de RSU |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Brun Scott C. |
Director |
Attribution de RSU |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-03-01 |
Nichtberger Steven |
President & CEO |
Attribution de RSU |
353,000 |
$23.97 |
$8.46M |
353,000 |
| 2024-03-01 |
Marda Anup |
Chief Financial Officer |
Attribution de RSU |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Chang David J. |
Chief Medical Officer |
Attribution de RSU |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Binder Gwendolyn |
See Remarks |
Attribution de RSU |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Gerard Michael |
General Counsel |
Attribution de RSU |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-03-01 |
Das Arun |
Chief Business Officer |
Attribution de RSU |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-01-19 |
Binder Gwendolyn |
See Remarks |
Vente Informative |
700 |
$20.33 |
$14.23K |
20,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
